Hi all,
There appears to be a new article in BioTechnologyNews.net entitled: 'Fermiscan to appeal decision on inventor', dated 16th June.
The link to it is as follows:
http://www.biotechnologynews.net/StoryView.asp?StoryID=1003303
At one stage I had a temporary subscription to this site which lapsed, but they still send me the e-mails (as these types of sites do).
It has the following summary, before getting you to sign in for the full story:
>>>>>>>>>>>>>
"FERMISCAN will appeal a recent decision of the NSW Supreme Court that ruled the inventor of the company’s core technology was not obliged to hand over new patents relating to the detection of cancer through the analysis of skin and tissue samples...
(16 June 2009) Full Story"
<<<<<<<<<<<<<<<<<
If anybody happens to have a subscription and is so inclined, please have a look and post a copy (if that's OK re copyright etc.).
Cheers.
- Forums
- ASX - By Stock
- fermiscan to appeal decision on inventor
PLT
plenti group limited
Add to My Watchlist
5.04%
!
$1.25

Hi all,There appears to be a new article in...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.25 |
Change
0.060(5.04%) |
Mkt cap ! $224.2M |
Open | High | Low | Value | Volume |
$1.16 | $1.25 | $1.16 | $218.5K | 181.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 31868 | $1.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 2819 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31730 | 1.240 |
1 | 4056 | 1.230 |
1 | 2041 | 1.215 |
2 | 5250 | 1.200 |
1 | 50000 | 1.180 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 2819 | 1 |
1.300 | 19534 | 2 |
1.350 | 476 | 1 |
1.370 | 4600 | 1 |
1.440 | 36328 | 2 |
Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
Featured News
PLT (ASX) Chart |
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online